Potassium chloride extended release
- Product NDC
- 0574-0274
- 11-digit product format
- 005740274
- Labeler code
- 0574
- Product ID
- 0574-0274_2e43611f-2079-4062-9aac-7bac0e103a3e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Potassium chloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Padagis US LLC
- Application
- ANDA205993
- Marketing category
- ANDA
- Marketing start
- 2015-12-11
- Marketing end
- 2023-07-31
- Substance
- POTASSIUM CHLORIDE
- Active strength
- 600 mg/1
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0574-0274-01 | 00574027401 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0274-01) | 2016-01-06 | 0000-00-00 | No | No | Current |
| 0574-0274-05 | 00574027405 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0274-05) | 2016-01-12 | 0000-00-00 | No | No | Current |